InvestorsHub Logo
Followers 25
Posts 2423
Boards Moderated 0
Alias Born 07/25/2013

Re: None

Friday, 04/28/2017 9:16:05 AM

Friday, April 28, 2017 9:16:05 AM

Post# of 345681
History and Practice:
Antibodies in Infectious Diseases
ADAM HEY1
1Preclinical Safety, Biologics, Novartis AG, Basel, Switzerland

From 2015 but Peregrine/Bavitusximab in there.

http://www.asmscience.org/docserver/fulltext/microbiolspec/3/2/AID-0026-2014.pdf?expires=1493385999&id=id&accname=guest&checksum=7A0A8976BF0AE06CC8314EBFAC033C9C
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News